Global & China Laparoscopic Devices Market to 2031

The laparoscopic devices market in China is rapidly evolving and expanding, driven by the country’s large population, rising healthcare spending, and strong governmental support for advanced medical technologies, especially minimally invasive surgery. As the world’s second-largest medical device market, China is expected to maintain its leading position due to factors such as an aging population, increased prevalence of chronic diseases, and initiatives like “Made in China 2025,” which emphasize domestic production of high-end medical equipment. In 2023, China performed 270,089 bariatric surgeries, with sleeve gastrectomy and Roux-en-Y gastric bypass (RYGB) being the predominant procedures, reflecting the widespread use of laparoscopic methods in this area.

Laparoscopic instruments play a crucial role in many general surgical procedures, supported by the growing demand driven by chronic illnesses and the aging demographic requiring more surgeries. The market for laparoscopic surgical robotic devices—a subset of minimally invasive technology—is also expanding rapidly, with general surgery among the fastest-growing applications. Ongoing innovation in disposable laparoscopic tools further contributes to market growth.

In colorectal cancer treatment, laparoscopic surgery has transformed patient care by reducing postoperative pain, lowering infection rates, shortening hospital stays, and enabling faster recoveries. A study conducted at Tianjin Medical University Cancer Institute and Hospital between January 2021 and June 2024 compared robotic-assisted colorectal surgery (RACS) and laparoscopic colorectal surgery (LCS), demonstrating a high volume of procedures. Additionally, a multicenter trial across 22 major Chinese centers up to 2024 confirmed that laparoscopic surgery performed by experienced surgeons yields comparable 3-year disease-free survival outcomes to open surgery for low rectal cancer. These findings highlight the established and increasingly advanced role of laparoscopic techniques in colorectal cancer management.

In gynecology, laparoscopic devices are extensively utilized, driven by a rise in obstetrical and gynecological surgeries—approximately 31 million in 2023 compared to 29.7 million in 2019. Research, including retrospective studies from June 2018 to May 2023, demonstrates ongoing high volumes and continuous investigation into laparoscopic gynecological procedures. Robotic surgery, often building on laparoscopic foundations, is gaining momentum in gynecologic oncology. For instance, a November 2024 study assessed the cost-effectiveness of robotic versus conventional laparoscopic surgery for early-stage cervical cancer. Events like the Fourth International Elite Gynecologic Surgery Competition in 2024, hosted by AME Publishing Company and West China Second University Hospital, underscore China’s emphasis on advancing minimally invasive and laparoscopic gynecologic surgery through surgical video contests and professional training.

Overall, China’s commitment to enhancing healthcare infrastructure, its large patient population, and increasing investment in cutting-edge medical technologies are driving strong growth in the laparoscopic devices market across multiple surgical specialties. Major market participants include Medtronic, Stryker Corporation, Johnson & Johnson, Karl Storz, and Olympus, alongside a rising number of domestic manufacturers. Show more